Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Drug Recall Totals for 2008 Highlight Global Outsourcing and Other Risks

This article was originally published in The Gold Sheet

Executive Summary

Drug recalls surged last year as global outsourcing took toll. Inappropriate ingredients from China contributed to record 32 Class I recalls, including heparin adulterant and erectile dysfunction API. Meanwhile, U.S. facilities help drive total recalls to 426 - the highest level in seven years. Economic forces and corporate culture played contributing roles. Sage, Hydrox, Sandoz, KV, Actavis, other recall cases explored.

Related Content

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts